Literature DB >> 29686008

Could 130/80 mm Hg Be Adopted as the Diagnostic Threshold and Management Goal of Hypertension in Consideration of the Characteristics of Asian Populations?

Kazuomi Kario1,2, Ji-Guang Wang3,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29686008     DOI： 10.1161/HYPERTENSIONAHA.118.11203

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  30 in total

Review 1.  Impact of the 2017 American College of Cardiology/American Heart Association Blood Pressure Guidelines on the Next Blood Pressure Guidelines in Asia.

Authors:  Naoki Nakagawa; Naoyuki Hasebe
Journal:  Curr Hypertens Rep       Date:  2019-01-10       Impact factor: 5.369

Review 2.  Strategies for improving the treatment and control of hypertension in Japan.

Authors:  Atsushi Sakima; Tetsutaro Matayoshi; Hisatomi Arima
Journal:  J Hum Hypertens       Date:  2022-06-03       Impact factor: 3.012

3.  Latest hypertension research to inform clinical practice in Asia.

Authors:  Kazuomi Kario; Masaki Mogi; Satoshi Hoshide
Journal:  Hypertens Res       Date:  2022-04-05       Impact factor: 5.528

4.  Expert panel consensus recommendations for ambulatory blood pressure monitoring in Asia: The HOPE Asia Network.

Authors:  Kazuomi Kario; Jinho Shin; Chen-Huan Chen; Peera Buranakitjaroen; Yook-Chin Chia; Romeo Divinagracia; Jennifer Nailes; Satoshi Hoshide; Saulat Siddique; Jorge Sison; Arieska Ann Soenarta; Guru Prasad Sogunuru; Jam Chin Tay; Boon Wee Teo; Yuda Turana; Yuqing Zhang; Sungha Park; Huynh Van Minh; Ji-Guang Wang
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-09       Impact factor: 3.738

5.  Single-pill combination of cilnidipine, an L-/N-type calcium channel blocker, and valsartan effectively reduces home pulse pressure in patients with uncontrolled hypertension and sympathetic hyperactivity: The HOPE-Combi survey.

Authors:  Kazuomi Kario; Saori Matsuda; Shinobu Nagahama; Yoshiki Kurose; Hitoshi Sugii; Tsukasa Teshima; Noriyuki Suzuki
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-03       Impact factor: 3.738

6.  Trajectories of Systolic Blood Pressure in Children: Risk Factors and Cardiometabolic Correlates.

Authors:  Wen Lun Yuan; Michael S Kramer; Navin Michael; Suresh A Sadananthan; Mya T Tint; Ling-Wei Chen; Wei Wei Pang; Sendhil S Velan; Keith M Godfrey; Yap-Seng Chong; Mary F F Chong; Jonathan T L Choo; Lieng Hsi Ling; Johan G Eriksson; Yung Seng Lee
Journal:  J Pediatr       Date:  2021-05-18       Impact factor: 4.406

7.  Faculty Service-Learning Students as Home-Visitors: Outcomes of a Lifestyle Modification Program for Vulnerable Families With Residents in Rural Indonesian Communities.

Authors:  Stephen Wai Hang Kwok; Phyllis Chui Ping Pang; Man Hon Chung; Cynthia Sau Ting Wu
Journal:  Front Public Health       Date:  2021-05-12

8.  Home blood pressure control status in 2017-2018 for hypertension specialist centers in Asia: Results of the Asia BP@Home study.

Authors:  Kazuomi Kario; Naoko Tomitani; Peera Buranakitjaroen; Yook-Chin Chia; Sungha Park; Chen-Huan Chen; Romeo Divinagracia; Jinho Shin; Saulat Siddique; Jorge Sison; Arieska Ann Soenarta; Guru Prasad Sogunuru; Jam Chin Tay; Yuda Turana; Yuqing Zhang; Jennifer Nailes; Sirisawat Wanthong; Satoshi Hoshide; Noriko Matsushita; Hiroshi Kanegae; Ji-Guang Wang
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-11-16       Impact factor: 3.738

9.  Prevalence and prognosis of the 2018 vs 2008 AHA definitions of apparent treatment-resistant hypertension in high-risk hypertension patients.

Authors:  Kyeong-Hyeon Chun; Chan Joo Lee; Jaewon Oh; Sang-Hak Lee; Seok-Min Kang; Kazuomi Kario; Sungha Park
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-09-20       Impact factor: 3.738

Review 10.  The HOPE Asia Network activity for "zero" cardiovascular events in Asia: Overview 2020.

Authors:  Kazuomi Kario
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-02-24       Impact factor: 3.738
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.